Strategically advanced, they enable you to benefit from the expertise of institutional portfolio managers all for a minimum investment of $500! Omega FundsTM give you the opportunity to diversify your investment portfolio and maximize return potential.
| Company | Date | Round | Size | Participants |
| SpineVision | 5/13 | Private Equity | $10M | 3 |
| Visterra | 11/12 | Series A | $13M | 5 |
| Egalet | 5/12 | Series B | $14.3M | 5 |
| Oxagen | 11/09 | Series C | $26.7M | 9 |
| Elixir Pharmaceuticals | 5/09 | Series D | $12M | 5 |
| Intarcia Therapeutics | 3/07 | Series A | 5 | |
| Neurotech | 11/06 | Series B | $35M | 12 |
| Celletra | 3/05 | Venture Round | $5.7M | 6 |
